Randomized comparison of interferon-alpha vs chemotherapy in patients with Philadelphia-negative chronic myelogenous leukemia (CML).

被引:0
|
作者
Hochhaus, A [1 ]
Hehlmann, R [1 ]
Bartram, CR [1 ]
Heimpel, H [1 ]
Reiter, A [1 ]
Berger, U [1 ]
Ansari, H [1 ]
Skladny, H [1 ]
Heinze, B [1 ]
Hossfeld, DK [1 ]
机构
[1] UNIV HEIDELBERG,KLINIKUM MANNHEIM,GERMAN CML STUDY GRP,MED KLIN 3,MANNHEIM,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2298 / 2298
页数:1
相关论文
共 50 条
  • [1] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    ANSARI, H
    [J]. BLOOD, 1994, 84 (10) : A382 - A382
  • [2] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    GEORGII, A
    BARTRAM, CR
    GRIESSHAMMER, M
    BERGMANN, L
    ESSERS, U
    FALGE, C
    QUEISSER, U
    MEYER, P
    SCHMITZ, N
    EIMERMACHER, H
    WALTHER, F
    FETT, W
    KLEEBERG, UR
    KABISCH, A
    NERL, C
    ZIMMERMANN, R
    MEURET, G
    TICHELLI, A
    KANZ, L
    TIGGES, FJ
    SCHMID, L
    BROCKHAUS, W
    TOBLER, A
    REITER, A
    PERKER, M
    EMMERICH, B
    VERPOORT, K
    ZANKOVICH, R
    VONWUSSOW, P
    PRUMMER, O
    THIELE, J
    BUHR, T
    CARBONELL, F
    ANSARI, H
    [J]. BLOOD, 1994, 84 (12) : 4064 - 4077
  • [3] RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS BUSULFAN - PROLONGATION OF SURVIVAL BY INTERFERON-ALPHA IN CHRONIC PHASE CML
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    HOSSFELD, DK
    HEINZE, B
    HOCHHAUS, A
    PRALLE, H
    QUEISSER, W
    LOFFLER, H
    ANSARI, H
    [J]. BLOOD, 1993, 82 (10) : A330 - A330
  • [4] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    [J]. BLOOD, 1999, 94 (10) : 279B - 279B
  • [5] Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha
    Carella, AM
    Simonsson, B
    Link, H
    Lennard, A
    Boogaerts, M
    Gorin, NC
    Tomas-Martinez, JF
    Dabouz-Harrouche, F
    Gautier, L
    Badri, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 111 - 118
  • [6] INTENSIVE CHEMOTHERAPY INDUCTION FOLLOWED BY INTERFERON-ALPHA MAINTENANCE IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    KANTARJIAN, HM
    TALPAZ, M
    KEATING, MJ
    ESTEY, EH
    OBRIEN, S
    BERAN, M
    MCCREDIE, KB
    GUTTERMAN, J
    FREIREICH, EJ
    [J]. CANCER, 1991, 68 (06) : 1201 - 1207
  • [7] Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy
    Kantarjian, HM
    Giles, FJ
    O'Brien, SM
    Talpaz, M
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (01) : 31 - +
  • [8] SELECTION OF PHILADELPHIA-NEGATIVE PROGENITORS FROM CHRONIC MYELOGENOUS LEUKEMIA
    CARLOSTELLA, C
    MANGONI, L
    PIOVANI, G
    GARAU, D
    DOTTI, GP
    ALMICI, C
    RIZZOLI, V
    [J]. BONE MARROW TRANSPLANTATION, 1994, 14 : S45 - S48
  • [9] Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
    Hasselbalch, Hans Carl
    Larsen, Thomas Stauffer
    Riley, Caroline Hasselbalch
    Jensen, Morten Krogh
    Kiladjian, Jean-Jacques
    [J]. CURRENT DRUG TARGETS, 2011, 12 (03) : 392 - 419
  • [10] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA
    GUILHOT, F
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (02): : 200 - 201